Skip to main content
Top
Published in: Brain Structure and Function 7/2022

Open Access 19-07-2022 | Tremor | Review

Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review

Authors: Jackson Tyler Boonstra, Hugo McGurran, Yasin Temel, Ali Jahanshahi

Published in: Brain Structure and Function | Issue 7/2022

Login to get access

Abstract

The neuropathological substrates of Parkinson’s disease (PD) patients with motor subtypes tremor-dominance (TD), non-tremor dominance (nTD), postural instability and gait difficulty (PIGD), and akinetic-rigid (AR) are not completely differentiated. While extensive pathological research has been conducted on neuronal tissue of PD patients, data have not been discussed in the context of mechanistic circuitry theories differentiating motor subtypes. It is, therefore, expected that a more specific and tailored management of PD symptoms can be accomplished by understanding symptom-specific neuropathological mechanisms with the detail histology can provide. This scoping review gives an overview of the literature comparing TD and nTD PD motor subtypes by clarify observed pathology with underlying physiological circuitry theories. Studies using an array of pathological examination techniques have shown significant differences between TD and nTD PD subtypes. nTD PD patients show higher neuronal loss, gliosis, extraneuronal melanin deposits, and neuroaxonal dystrophy in multiple subregions of the substantia nigra (SN) related to the overactivity of the indirect motor loop. TD patients show more severe cell loss specifically in medial SN subdivisions, and have damage in the retrorubral field A-8 that projects to the dorsolateral striatum and ventromedial thalamus in the direct motor loop. Pathological studies are consistent with neuroimaging data and support contemporary mechanistic circuitry theories of PD motor symptom genesis. Further multimodal neuroimaging and histological studies are required to validate and expand upon these findings.
Appendix
Available only for authorised users
Literature
go back to reference Al-Bachari S, Vidyasagar R, Emsley HC, Parkes LM (2017) Structural and physiological neurovascular changes in idiopathic Parkinson’s disease and its clinical phenotypes. J Cereb Blood Flow Metab 37:3409–3421PubMedPubMedCentralCrossRef Al-Bachari S, Vidyasagar R, Emsley HC, Parkes LM (2017) Structural and physiological neurovascular changes in idiopathic Parkinson’s disease and its clinical phenotypes. J Cereb Blood Flow Metab 37:3409–3421PubMedPubMedCentralCrossRef
go back to reference Alexander GE (2004) Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6:259–280PubMedPubMedCentralCrossRef Alexander GE (2004) Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6:259–280PubMedPubMedCentralCrossRef
go back to reference Alkemade A, Mulder MJ, Groot JM, Isaacs BR, van Berendonk N, Lute N, Isherwood SJ, Bazin PL, Forstmann BU (2020) The Amsterdam Ultra-high field adult lifespan database (AHEAD): a freely available multimodal 7 Tesla submillimeter magnetic resonance imaging database. Neuroimage 221:117200PubMedCrossRef Alkemade A, Mulder MJ, Groot JM, Isaacs BR, van Berendonk N, Lute N, Isherwood SJ, Bazin PL, Forstmann BU (2020) The Amsterdam Ultra-high field adult lifespan database (AHEAD): a freely available multimodal 7 Tesla submillimeter magnetic resonance imaging database. Neuroimage 221:117200PubMedCrossRef
go back to reference Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32CrossRef Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32CrossRef
go back to reference Ashkan K, Rogers P, Bergman H, Ughratdar I (2017) Insights into the mechanisms of deep brain stimulation. Nat Rev Neurol 13:548–554PubMedCrossRef Ashkan K, Rogers P, Bergman H, Ughratdar I (2017) Insights into the mechanisms of deep brain stimulation. Nat Rev Neurol 13:548–554PubMedCrossRef
go back to reference Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvogel D (2009) Morphological differences in Parkinson’s disease with and without rest tremor. J Neurol 256:256–263PubMedCrossRef Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvogel D (2009) Morphological differences in Parkinson’s disease with and without rest tremor. J Neurol 256:256–263PubMedCrossRef
go back to reference Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455PubMedCrossRef Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455PubMedCrossRef
go back to reference Boonstra JT, Michielse S, Temel Y, Hoogland G, Jahanshahi A (2021) Neuroimaging detectable differences between Parkinson’s disease motor subtypes: a systematic review. Mov Disord Clin Pract 8:175–192PubMedCrossRef Boonstra JT, Michielse S, Temel Y, Hoogland G, Jahanshahi A (2021) Neuroimaging detectable differences between Parkinson’s disease motor subtypes: a systematic review. Mov Disord Clin Pract 8:175–192PubMedCrossRef
go back to reference Borghammer P (2018) How does Parkinson’s disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord 33:48–57PubMedCrossRef Borghammer P (2018) How does Parkinson’s disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord 33:48–57PubMedCrossRef
go back to reference Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef
go back to reference Bunzeck N, Singh-Curry V, Eckart C, Weiskopf N, Perry RJ, Bain PG, Duzel E, Husain M (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19:1136–1142PubMedPubMedCentralCrossRef Bunzeck N, Singh-Curry V, Eckart C, Weiskopf N, Perry RJ, Bain PG, Duzel E, Husain M (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19:1136–1142PubMedPubMedCentralCrossRef
go back to reference Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30:895–903PubMedPubMedCentralCrossRef Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30:895–903PubMedPubMedCentralCrossRef
go back to reference Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson’s disease progression and related dementia. Neurodegener Dis 13:154–156PubMedCrossRef Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson’s disease progression and related dementia. Neurodegener Dis 13:154–156PubMedCrossRef
go back to reference Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain 122(Pt 8):1437–1448PubMedCrossRef Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain 122(Pt 8):1437–1448PubMedCrossRef
go back to reference De Pablo-Fernandez E, Lees AJ, Holton JL, Warner TT (2019) Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 76:470–479PubMedPubMedCentralCrossRef De Pablo-Fernandez E, Lees AJ, Holton JL, Warner TT (2019) Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 76:470–479PubMedPubMedCentralCrossRef
go back to reference Deutch AY, Goldstein M, Baldino F Jr, Roth RH (1988) Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci 537:27–50PubMedCrossRef Deutch AY, Goldstein M, Baldino F Jr, Roth RH (1988) Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci 537:27–50PubMedCrossRef
go back to reference Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976PubMedCrossRef Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976PubMedCrossRef
go back to reference Gibb WR, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry 54:388–396PubMedPubMedCentralCrossRef Gibb WR, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry 54:388–396PubMedPubMedCentralCrossRef
go back to reference Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47PubMedCrossRef Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47PubMedCrossRef
go back to reference Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35:4–26PubMedCrossRef Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35:4–26PubMedCrossRef
go back to reference Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JG (1996) Midbrain neuropathology in idiopathic Parkinson’s disease and diffuse Lewy body disease. J Clin Neurosci 3:52–60PubMedCrossRef Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JG (1996) Midbrain neuropathology in idiopathic Parkinson’s disease and diffuse Lewy body disease. J Clin Neurosci 3:52–60PubMedCrossRef
go back to reference He N, Huang P, Ling H, Langley J, Liu C, Ding B, Huang J, Xu H, Zhang Y, Zhang Z, Hu X, Chen S, Yan F (2017) Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson’s disease. NMR Biomed 30:e3554CrossRef He N, Huang P, Ling H, Langley J, Liu C, Ding B, Huang J, Xu H, Zhang Y, Zhang Z, Hu X, Chen S, Yan F (2017) Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson’s disease. NMR Biomed 30:e3554CrossRef
go back to reference Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR (2012) Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain 135:3206–3226PubMedPubMedCentralCrossRef Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR (2012) Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain 135:3206–3226PubMedPubMedCentralCrossRef
go back to reference Herb JN, Rane S, Isaacs DA, Van Wouwe N, Roman OC, Landman BA, Dawant BM, Hedera P, Zald DH, Neimat JS, Wylie SA, Donahue MJ, Claassen DO (2016) Cortical implications of advancing age and disease duration in Parkinson’s disease patients with postural instability and gait dysfunction. J Parkinsons Dis 6:441–451PubMedPubMedCentralCrossRef Herb JN, Rane S, Isaacs DA, Van Wouwe N, Roman OC, Landman BA, Dawant BM, Hedera P, Zald DH, Neimat JS, Wylie SA, Donahue MJ, Claassen DO (2016) Cortical implications of advancing age and disease duration in Parkinson’s disease patients with postural instability and gait dysfunction. J Parkinsons Dis 6:441–451PubMedPubMedCentralCrossRef
go back to reference Hirsch EC, Mouatt A, Graybiel AM, Javoy-Agid F, Agid Y (1991) The loss of catecholami-nergic neurons in Parkinson’s disease is heterogeneous in the midbrain. 10th international symposium on Parkinson’s disease. In: 10th International Symposium on Parkinson’s disease Hirsch EC, Mouatt A, Graybiel AM, Javoy-Agid F, Agid Y (1991) The loss of catecholami-nergic neurons in Parkinson’s disease is heterogeneous in the midbrain. 10th international symposium on Parkinson’s disease. In: 10th International Symposium on Parkinson’s disease
go back to reference Hutchison WD, Dostrovsky JO, Walters JR, Courtemanche R, Boraud T, Goldberg J, Brown P (2004) Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J Neurosci 24:9240–9243PubMedPubMedCentralCrossRef Hutchison WD, Dostrovsky JO, Walters JR, Courtemanche R, Boraud T, Goldberg J, Brown P (2004) Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J Neurosci 24:9240–9243PubMedPubMedCentralCrossRef
go back to reference Jankovic J, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. Neurology 40:1529PubMedCrossRef Jankovic J, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. Neurology 40:1529PubMedCrossRef
go back to reference Jellinger K (1999) Post mortem studies in Parkinson’s disease—is it possible to detect brain areas for specific symptoms. Journal of neural transmission, supplement. Springer, Vienna Jellinger K (1999) Post mortem studies in Parkinson’s disease—is it possible to detect brain areas for specific symptoms. Journal of neural transmission, supplement. Springer, Vienna
go back to reference Jellinger KA, Paulus W (1992) Clinico-pathological correlations in Parkinson’s disease. Clin Neurol Neurosurg 94(Suppl):S86–S88PubMedCrossRef Jellinger KA, Paulus W (1992) Clinico-pathological correlations in Parkinson’s disease. Clin Neurol Neurosurg 94(Suppl):S86–S88PubMedCrossRef
go back to reference Karunanayaka PR, Lee EY, Lewis MM, Sen S, Eslinger PJ, Yang QX, Huang X (2016) Default mode network differences between rigidity- and tremor-predominant Parkinson’s disease. Cortex 81:239–250PubMedPubMedCentralCrossRef Karunanayaka PR, Lee EY, Lewis MM, Sen S, Eslinger PJ, Yang QX, Huang X (2016) Default mode network differences between rigidity- and tremor-predominant Parkinson’s disease. Cortex 81:239–250PubMedPubMedCentralCrossRef
go back to reference Lee JW, Song YS, Kim H, Ku BD, Lee WW (2019) Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson’s disease: analysis of the PPMI cohort. Front Neurol 10:471PubMedPubMedCentralCrossRef Lee JW, Song YS, Kim H, Ku BD, Lee WW (2019) Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson’s disease: analysis of the PPMI cohort. Front Neurol 10:471PubMedPubMedCentralCrossRef
go back to reference Linder J, Birgander R, Olsson I, Riklund K, Larsson AK, Edstrom M, Stenlund H, Forsgren L (2009) Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort. J Neurol 256:1671–1680PubMedCrossRef Linder J, Birgander R, Olsson I, Riklund K, Larsson AK, Edstrom M, Stenlund H, Forsgren L (2009) Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort. J Neurol 256:1671–1680PubMedCrossRef
go back to reference Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM, P. Group Parkinson’s Foundation (2018) Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 4:21PubMedPubMedCentralCrossRef Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM, P. Group Parkinson’s Foundation (2018) Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 4:21PubMedPubMedCentralCrossRef
go back to reference Martin-Bastida A, Lao-Kaim NP, Loane C, Politis M, Roussakis AA, Valle-Guzman N, Kefalopoulou Z, Paul-Visse G, Widner H, Xing Y, Schwarz ST, Auer DP, Foltynie T, Barker RA, Piccini P (2017) Motor associations of iron accumulation in deep grey matter nuclei in Parkinson’s disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. Eur J Neurol 24:357–365PubMedCrossRef Martin-Bastida A, Lao-Kaim NP, Loane C, Politis M, Roussakis AA, Valle-Guzman N, Kefalopoulou Z, Paul-Visse G, Widner H, Xing Y, Schwarz ST, Auer DP, Foltynie T, Barker RA, Piccini P (2017) Motor associations of iron accumulation in deep grey matter nuclei in Parkinson’s disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. Eur J Neurol 24:357–365PubMedCrossRef
go back to reference Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA (2017) 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. Neuroimage Clin 13:154–163PubMedCrossRef Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA (2017) 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. Neuroimage Clin 13:154–163PubMedCrossRef
go back to reference McRitchie DA, Cartwright HR, Halliday GM (1997) Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson’s disease. Exp Neurol 144:202–213PubMedCrossRef McRitchie DA, Cartwright HR, Halliday GM (1997) Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson’s disease. Exp Neurol 144:202–213PubMedCrossRef
go back to reference Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Front Neurol 10:391PubMedPubMedCentralCrossRef Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Front Neurol 10:391PubMedPubMedCentralCrossRef
go back to reference Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD (2016) Microstructural changes within the basal ganglia differ between Parkinson disease subtypes. Front Neuroanat 10:17PubMedPubMedCentralCrossRef Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD (2016) Microstructural changes within the basal ganglia differ between Parkinson disease subtypes. Front Neuroanat 10:17PubMedPubMedCentralCrossRef
go back to reference Nambu A, Tachibana Y, Chiken S (2015) Cause of parkinsonian symptoms: firing rate, firing pattern or dynamic activity changes? Basal Ganglia 5:1–6CrossRef Nambu A, Tachibana Y, Chiken S (2015) Cause of parkinsonian symptoms: firing rate, firing pattern or dynamic activity changes? Basal Ganglia 5:1–6CrossRef
go back to reference Neudorfer C, Hinzke M, Hunsche S, El Majdoub F, Lozano A, Maarouf M (2019) Combined deep brain stimulation of subthalamic nucleus and ventral intermediate thalamic nucleus in tremor-dominant Parkinson’s disease using a parietal approach. Neuromodulation 22:493–502PubMedCrossRef Neudorfer C, Hinzke M, Hunsche S, El Majdoub F, Lozano A, Maarouf M (2019) Combined deep brain stimulation of subthalamic nucleus and ventral intermediate thalamic nucleus in tremor-dominant Parkinson’s disease using a parietal approach. Neuromodulation 22:493–502PubMedCrossRef
go back to reference Neumann WJ, Schroll H, de Almeida Marcelino AL, Horn A, Ewert S, Irmen F, Krause P, Schneider GH, Hamker F, Kuhn AA (2018) Functional segregation of basal ganglia pathways in Parkinson’s disease. Brain 141:2655–2669PubMed Neumann WJ, Schroll H, de Almeida Marcelino AL, Horn A, Ewert S, Irmen F, Krause P, Schneider GH, Hamker F, Kuhn AA (2018) Functional segregation of basal ganglia pathways in Parkinson’s disease. Brain 141:2655–2669PubMed
go back to reference Nyberg EM, Tanabe J, Honce JM, Krmpotich T, Shelton E, Hedeman J, Berman BD (2015) Morphologic changes in the mesolimbic pathway in Parkinson’s disease motor subtypes. Parkinsonism Relat Disord 21:536–540PubMedPubMedCentralCrossRef Nyberg EM, Tanabe J, Honce JM, Krmpotich T, Shelton E, Hedeman J, Berman BD (2015) Morphologic changes in the mesolimbic pathway in Parkinson’s disease motor subtypes. Parkinsonism Relat Disord 21:536–540PubMedPubMedCentralCrossRef
go back to reference Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson’s disease. Trends Neurosci 23:S8-19PubMedCrossRef Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson’s disease. Trends Neurosci 23:S8-19PubMedCrossRef
go back to reference Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128–154PubMedCrossRef Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128–154PubMedCrossRef
go back to reference Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50:743–755PubMedCrossRef Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50:743–755PubMedCrossRef
go back to reference Piccinin CC, Campos LS, Guimaraes RP, Piovesana LG, Dos Santos MCA, Azevedo PC, Campos BM, de Rezende TJR, Amato-Filho A, Cendes F, D’Abreu A (2017) Differential pattern of cerebellar atrophy in tremor-predominant and akinetic/rigidity-predominant Parkinson’s disease. Cerebellum 16:623–628PubMedCrossRef Piccinin CC, Campos LS, Guimaraes RP, Piovesana LG, Dos Santos MCA, Azevedo PC, Campos BM, de Rezende TJR, Amato-Filho A, Cendes F, D’Abreu A (2017) Differential pattern of cerebellar atrophy in tremor-predominant and akinetic/rigidity-predominant Parkinson’s disease. Cerebellum 16:623–628PubMedCrossRef
go back to reference Plantinga BR, Roebroeck A, Kemper VG, Uludag K, Melse M, Mai J, Kuijf ML, Herrler A, Jahanshahi A, Ter Haar Romeny BM, Temel Y (2016) Ultra-high field MRI post mortem structural connectivity of the human subthalamic nucleus, substantia nigra, and globus pallidus. Front Neuroanat 10:66PubMedPubMedCentralCrossRef Plantinga BR, Roebroeck A, Kemper VG, Uludag K, Melse M, Mai J, Kuijf ML, Herrler A, Jahanshahi A, Ter Haar Romeny BM, Temel Y (2016) Ultra-high field MRI post mortem structural connectivity of the human subthalamic nucleus, substantia nigra, and globus pallidus. Front Neuroanat 10:66PubMedPubMedCentralCrossRef
go back to reference Prodoehl J, Planetta PJ, Kurani AS, Comella CL, Corcos DM, Vaillancourt DE (2013) Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol 70:100–106PubMedPubMedCentralCrossRef Prodoehl J, Planetta PJ, Kurani AS, Comella CL, Corcos DM, Vaillancourt DE (2013) Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol 70:100–106PubMedPubMedCentralCrossRef
go back to reference Rajput AH, Pahwa R, Pahwa P, Rajput A (1993) Prognostic significance of the onset mode in parkinsonism. Neurology 43:829–830PubMedCrossRef Rajput AH, Pahwa R, Pahwa P, Rajput A (1993) Prognostic significance of the onset mode in parkinsonism. Neurology 43:829–830PubMedCrossRef
go back to reference Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403–1410PubMedCrossRef Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403–1410PubMedCrossRef
go back to reference Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73:206–212PubMedCrossRef Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73:206–212PubMedCrossRef
go back to reference Ren J, Pan C, Li Y, Li L, Hua P, Xu L, Zhang L, Zhang W, Xu P, Liu W (2021) Consistency and stability of motor subtype classifications in patients with de novo Parkinson’s disease. Front Neurosci 15:637896PubMedPubMedCentralCrossRef Ren J, Pan C, Li Y, Li L, Hua P, Xu L, Zhang L, Zhang W, Xu P, Liu W (2021) Consistency and stability of motor subtype classifications in patients with de novo Parkinson’s disease. Front Neurosci 15:637896PubMedPubMedCentralCrossRef
go back to reference Rinne JO, Rummukainen J, Paljarvi L, Rinne UK (1989) Dementia in Parkinson’s disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26:47–50PubMedCrossRef Rinne JO, Rummukainen J, Paljarvi L, Rinne UK (1989) Dementia in Parkinson’s disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26:47–50PubMedCrossRef
go back to reference Rosenberg-Katz K, Herman T, Jacob Y, Giladi N, Hendler T, Hausdorff JM (2013) Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology 80:1476–1484PubMedPubMedCentralCrossRef Rosenberg-Katz K, Herman T, Jacob Y, Giladi N, Hendler T, Hausdorff JM (2013) Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology 80:1476–1484PubMedPubMedCentralCrossRef
go back to reference Rosenberg-Katz K, Herman T, Jacob Y, Kliper E, Giladi N, Hausdorff JM (2016) Subcortical volumes differ in Parkinson’s disease motor subtypes: new insights into the pathophysiology of disparate symptoms. Front Hum Neurosci 10:356PubMedPubMedCentralCrossRef Rosenberg-Katz K, Herman T, Jacob Y, Kliper E, Giladi N, Hausdorff JM (2016) Subcortical volumes differ in Parkinson’s disease motor subtypes: new insights into the pathophysiology of disparate symptoms. Front Hum Neurosci 10:356PubMedPubMedCentralCrossRef
go back to reference Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957PubMedCrossRef Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957PubMedCrossRef
go back to reference Shah N, Frey KA, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI (2016) Striatal and cortical beta-amyloidopathy and cognition in Parkinson’s disease. Mov Disord 31:111–117PubMedCrossRef Shah N, Frey KA, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI (2016) Striatal and cortical beta-amyloidopathy and cognition in Parkinson’s disease. Mov Disord 31:111–117PubMedCrossRef
go back to reference Shink E, Bevan MD, Bolam JP, Smith Y (1996) The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73:335–357PubMedCrossRef Shink E, Bevan MD, Bolam JP, Smith Y (1996) The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73:335–357PubMedCrossRef
go back to reference Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K, Investigators P (2016) How stable are Parkinson’s disease subtypes in de novo patients: analysis of the PPMI cohort? Parkinsonism Relat Disord 28:62–67PubMedCrossRef Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K, Investigators P (2016) How stable are Parkinson’s disease subtypes in de novo patients: analysis of the PPMI cohort? Parkinsonism Relat Disord 28:62–67PubMedCrossRef
go back to reference Smith Y, Bevan MD, Shink E, Bolam JP (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86:353–387PubMed Smith Y, Bevan MD, Shink E, Bolam JP (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86:353–387PubMed
go back to reference Sutton AC, Yu W, Calos ME, Smith AB, Ramirez-Zamora A, Molho ES, Pilitsis JG, Brotchie JM, Shin DS (2013) Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat. J Neurophysiol 109:363–374PubMedCrossRef Sutton AC, Yu W, Calos ME, Smith AB, Ramirez-Zamora A, Molho ES, Pilitsis JG, Brotchie JM, Shin DS (2013) Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat. J Neurophysiol 109:363–374PubMedCrossRef
go back to reference Ten Kate M, Visser PJ, Bakardjian H, Barkhof F, Sikkes SAM, van der Flier WM, Scheltens P, Hampel H, Habert MO, Dubois B, Tijms BM (2018) Gray matter network disruptions and regional amyloid beta in cognitively normal adults. Front Aging Neurosci 10:67PubMedPubMedCentralCrossRef Ten Kate M, Visser PJ, Bakardjian H, Barkhof F, Sikkes SAM, van der Flier WM, Scheltens P, Hampel H, Habert MO, Dubois B, Tijms BM (2018) Gray matter network disruptions and regional amyloid beta in cognitively normal adults. Front Aging Neurosci 10:67PubMedPubMedCentralCrossRef
go back to reference Tessa C, Giannelli M, Della Nave R, Lucetti C, Berti C, Ginestroni A, Bonuccelli U, Mascalchi M (2008) A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 29:674–680PubMedPubMedCentralCrossRef Tessa C, Giannelli M, Della Nave R, Lucetti C, Berti C, Ginestroni A, Bonuccelli U, Mascalchi M (2008) A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 29:674–680PubMedPubMedCentralCrossRef
go back to reference Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72:1378–1384PubMedPubMedCentralCrossRef Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72:1378–1384PubMedPubMedCentralCrossRef
go back to reference Valldeoriola F, Munoz E, Rumia J, Roldan P, Camara A, Compta Y, Marti MJ, Tolosa E (2019) Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson’s disease: a pilot study. Parkinsonism Relat Disord 60:153–157PubMedCrossRef Valldeoriola F, Munoz E, Rumia J, Roldan P, Camara A, Compta Y, Marti MJ, Tolosa E (2019) Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson’s disease: a pilot study. Parkinsonism Relat Disord 60:153–157PubMedCrossRef
go back to reference van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25:969–978PubMedCrossRef van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25:969–978PubMedCrossRef
go back to reference Vervoort G, Leunissen I, Firbank M, Heremans E, Nackaerts E, Vandenberghe W, Nieuwboer A (2016) Structural brain alterations in motor subtypes of Parkinson’s disease: evidence from probabilistic tractography and shape analysis. PLoS ONE 11:e0157743PubMedPubMedCentralCrossRef Vervoort G, Leunissen I, Firbank M, Heremans E, Nackaerts E, Vandenberghe W, Nieuwboer A (2016) Structural brain alterations in motor subtypes of Parkinson’s disease: evidence from probabilistic tractography and shape analysis. PLoS ONE 11:e0157743PubMedPubMedCentralCrossRef
go back to reference Wang L, Yan Y, Zhang L, Liu Y, Luo R, Chang Y (2021) Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease. J Neural Transm (vienna) 128:171–179CrossRef Wang L, Yan Y, Zhang L, Liu Y, Luo R, Chang Y (2021) Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease. J Neural Transm (vienna) 128:171–179CrossRef
go back to reference Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, Burlina A, Donati MA, Geurtz B, Grattan-Smith PJ, Haeussler M, Hoffmann GF, Jung H, de Klerk JB, van der Knaap MS, Kok F, Leuzzi V, de Lonlay P, Megarbane A, Monaghan H, Renier WO, Rondot P, Ryan MM, Seeger J, Smeitink JA, Steenbergen-Spanjers GC, Wassmer E, Weschke B, Wijburg FA, Wilcken B, Zafeiriou DI, Wevers RA (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133:1810–1822PubMedCrossRef Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, Burlina A, Donati MA, Geurtz B, Grattan-Smith PJ, Haeussler M, Hoffmann GF, Jung H, de Klerk JB, van der Knaap MS, Kok F, Leuzzi V, de Lonlay P, Megarbane A, Monaghan H, Renier WO, Rondot P, Ryan MM, Seeger J, Smeitink JA, Steenbergen-Spanjers GC, Wassmer E, Weschke B, Wijburg FA, Wilcken B, Zafeiriou DI, Wevers RA (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133:1810–1822PubMedCrossRef
go back to reference Wu ST, Ma Y, Zhang K, Zhang JG (2012) Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson’s disease. Chin Med J (engl) 125:4072–4075 Wu ST, Ma Y, Zhang K, Zhang JG (2012) Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson’s disease. Chin Med J (engl) 125:4072–4075
go back to reference Wu Y, Guo XY, Wei QQ, Ou RW, Song W, Cao B, Zhao B, Shang HF (2016) Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson’s disease patients. Acta Neurol Scand 133:330–337PubMedCrossRef Wu Y, Guo XY, Wei QQ, Ou RW, Song W, Cao B, Zhao B, Shang HF (2016) Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson’s disease patients. Acta Neurol Scand 133:330–337PubMedCrossRef
go back to reference Xiang Y, Gong T, Wu J, Li J, Chen Y, Wang Y, Li S, Cong L, Lin Y, Han Y, Yin L, Wang G, Du Y (2017) Subtypes evaluation of motor dysfunction in Parkinson’s disease using neuromelanin-sensitive magnetic resonance imaging. Neurosci Lett 638:145–150PubMedCrossRef Xiang Y, Gong T, Wu J, Li J, Chen Y, Wang Y, Li S, Cong L, Lin Y, Han Y, Yin L, Wang G, Du Y (2017) Subtypes evaluation of motor dysfunction in Parkinson’s disease using neuromelanin-sensitive magnetic resonance imaging. Neurosci Lett 638:145–150PubMedCrossRef
go back to reference Xu C, Zhuang P, Hallett M, Zhang Y, Li J, Li Y (2018) Parkinson’s disease motor subtypes show different responses to long-term subthalamic nucleus stimulation. Front Hum Neurosci 12:365PubMedPubMedCentralCrossRef Xu C, Zhuang P, Hallett M, Zhang Y, Li J, Li Y (2018) Parkinson’s disease motor subtypes show different responses to long-term subthalamic nucleus stimulation. Front Hum Neurosci 12:365PubMedPubMedCentralCrossRef
go back to reference Zaidel A, Arkadir D, Israel Z, Bergman H (2009) Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol 22:387–393PubMedCrossRef Zaidel A, Arkadir D, Israel Z, Bergman H (2009) Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol 22:387–393PubMedCrossRef
go back to reference Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, Possin KL, Nezamzadeh M, Weiner MW, Marks WJ Jr, Schuff N (2012) Regional alterations of brain microstructure in Parkinson’s disease using diffusion tensor imaging. Mov Disord 27:90–97PubMedCrossRef Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, Possin KL, Nezamzadeh M, Weiner MW, Marks WJ Jr, Schuff N (2012) Regional alterations of brain microstructure in Parkinson’s disease using diffusion tensor imaging. Mov Disord 27:90–97PubMedCrossRef
go back to reference Zhang Y, Larcher KM, Misic B, Dagher A (2017) Anatomical and functional organization of the human substantia nigra and its connections. Elife 6 Zhang Y, Larcher KM, Misic B, Dagher A (2017) Anatomical and functional organization of the human substantia nigra and its connections. Elife 6
Metadata
Title
Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review
Authors
Jackson Tyler Boonstra
Hugo McGurran
Yasin Temel
Ali Jahanshahi
Publication date
19-07-2022
Publisher
Springer Berlin Heidelberg
Published in
Brain Structure and Function / Issue 7/2022
Print ISSN: 1863-2653
Electronic ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-022-02531-9

Other articles of this Issue 7/2022

Brain Structure and Function 7/2022 Go to the issue